Russell Investments Group Ltd. decreased its holdings in PACS Group, Inc. (NYSE:PACS – Free Report) by 16.3% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 306,542 shares of the company’s stock after selling 59,860 shares during the quarter. Russell Investments Group Ltd. owned approximately 0.19% of PACS Group worth $12,737,000 as of its most recent filing with the SEC.
A number of other institutional investors and hedge funds have also recently bought and sold shares of PACS. Financial Management Professionals Inc. grew its stake in PACS Group by 54.9% during the 2nd quarter. Financial Management Professionals Inc. now owns 663 shares of the company’s stock valued at $28,000 after purchasing an additional 235 shares in the last quarter. Eurizon Capital SGR S.p.A. acquired a new position in shares of PACS Group in the 3rd quarter valued at approximately $34,000. GK Wealth Management LLC purchased a new position in shares of PACS Group during the 3rd quarter valued at approximately $41,000. KBC Group NV purchased a new position in shares of PACS Group during the 1st quarter valued at approximately $42,000. Finally, USA Financial Formulas acquired a new stake in shares of PACS Group during the third quarter worth approximately $46,000.
Insider Activity
In related news, CEO Jason Murray sold 167,434 shares of PACS Group stock in a transaction dated Wednesday, November 4th. The shares were sold at an average price of $50.24, for a total value of $8,411,884.16. Following the sale, the chief executive officer directly owned 53,954,101 shares in the company, valued at $2,710,654,034.24. This trade represents a 0.31% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Mark Hancock sold 186,696 shares of the business’s stock in a transaction dated Wednesday, November 4th. The shares were sold at an average price of $50.45, for a total transaction of $9,418,813.20. Following the transaction, the director directly owned 53,318,884 shares of the company’s stock, valued at $2,689,937,697.80. The trade was a 0.35% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 1,395,000 shares of company stock valued at $64,793,252. 70.10% of the stock is currently owned by company insiders.
Wall Street Analyst Weigh In
Several analysts recently issued reports on PACS shares. Wall Street Zen raised shares of PACS Group from a “buy” rating to a “strong-buy” rating in a report on Saturday. Weiss Ratings upgraded PACS Group from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday, November 4th. JPMorgan Chase & Co. boosted their price target on PACS Group from $47.00 to $58.00 and gave the company an “overweight” rating in a report on Friday, September 4th. Zacks Research lowered PACS Group from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, September 9th. Finally, Stephens upped their price target on PACS Group from $60.00 to $64.00 and gave the company an “overweight” rating in a research report on Thursday, November 5th. Seven analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat.com, PACS Group currently has an average rating of “Moderate Buy” and an average target price of $62.50.
Check Out Our Latest Stock Report on PACS
PACS Group Stock Up 1.4%
NYSE:PACS opened at $43.63 on Friday. The company has a current ratio of 0.80, a quick ratio of 0.80 and a debt-to-equity ratio of 0.22. The stock has a 50 day moving average of $45.45 and a 200-day moving average of $40.65. The firm has a market capitalization of $6.92 billion, a PE ratio of 24.65, a price-to-earnings-growth ratio of 1.59 and a beta of -0.14. PACS Group, Inc. has a 52 week low of $24.61 and a 52 week high of $51.68.
PACS Group (NYSE:PACS – Get Free Report) last announced its quarterly earnings results on Tuesday, November 3rd. The company reported $0.63 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.58 by $0.05. PACS Group had a return on equity of 31.98% and a net margin of 4.87%. The business had revenue of $1.50 billion for the quarter, compared to the consensus estimate of $1.46 billion. Analysts predict that PACS Group, Inc. will post 2.05 EPS for the current year.
PACS Group Company Profile
PACS Group, Inc. is a post-acute healthcare provider that operates skilled nursing and rehabilitation facilities. Its services include nursing care, physical and occupational therapy, and support for patients recovering from illness or injury, as well as care for people with ongoing or long-term needs. Founded in 2013, the company has expanded its network of facilities across the United States. Its operations are organized through affiliated entities, with care and services tailored to the needs of residents and patients in the communities it serves.
Recommended Stories
- Five stocks we like better than PACS Group
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
- 3 Dividend ETFs Offering Steadier Footing in a Shaky Market
- Lazard’s New ETF Targets Monthly Income With Junk Bonds
Want to see what other hedge funds are holding PACS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PACS Group, Inc. (NYSE:PACS – Free Report).
Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.
